i agree that anp has great potential however it will be a few years before it really skyrockets however it should increase slowly with the stages of the clinical phases that the drug goes through eg if phase 1 successful then a rerating will occur and so on, def in for long haul here with top ups at appropriate times but still have to be prepared to lose all still high risk at the moment bottom drawer for a while good luck all IMHO
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.699M | |||
| Open | High | Low | Value | Volume |
| 0.9¢ | 0.9¢ | 0.8¢ | $1.301K | 156.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 27 | 6745374 | 0.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.9¢ | 1257781 | 6 |
View Market Depth
| Last trade - 15.56pm 22/07/2025 (20 minute delay) ? |
| PER (ASX) Chart |